HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mari Hämäläinen Selected Research

Ankyrins

7/2023The regulation of TRPA1 expression and function by Th1 and Th2-type inflammation in human A549 lung epithelial cells.
3/2021Transient Receptor Potential Ankyrin 1 (TRPA1)-An Inflammation-Induced Factor in Human HaCaT Keratinocytes.
12/2020Transient Receptor Potential Ankyrin 1 (TRPA1) Is Involved in Upregulating Interleukin-6 Expression in Osteoarthritic Chondrocyte Models.
1/2019Transient Receptor Potential Ankyrin 1 Enhances Ovalbumin-Induced Acute Allergic Inflammation in Murine Models.
11/2016Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes.
1/2015Urate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice--potential role for transient receptor potential ankyrin 1 in gout.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mari Hämäläinen Research Topics

Disease

52Inflammation (Inflammations)
03/2024 - 01/2003
8Pain (Aches)
07/2023 - 01/2015
8Obesity
11/2022 - 08/2014
7Breast Neoplasms (Breast Cancer)
03/2024 - 12/2017
7Edema (Dropsy)
03/2024 - 12/2012
6Neurogenic Inflammation
07/2023 - 11/2016
6Fibrosis (Cirrhosis)
02/2023 - 05/2013
6Rheumatoid Arthritis
12/2021 - 01/2015
6Osteoarthritis
08/2021 - 01/2014
5Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 08/2014
5Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 01/2018
4Insulin Resistance
12/2023 - 08/2014
4Weight Gain
09/2022 - 12/2016
4Arthritis (Polyarthritis)
12/2021 - 01/2015
4Schizophrenia (Dementia Praecox)
12/2021 - 08/2014
3Lung Diseases (Lung Disease)
07/2023 - 01/2017
3Hypoxia (Hypoxemia)
01/2022 - 10/2015
3Alcoholism (Alcohol Abuse)
01/2022 - 01/2018
2Hypersensitivity (Allergy)
03/2024 - 01/2016
2Cough
07/2023 - 10/2021
2Asthma (Bronchial Asthma)
01/2022 - 02/2008
2Overweight
12/2021 - 08/2014
2Cardiotoxicity
02/2020 - 12/2017
2Hantavirus Infections
01/2019 - 01/2018
2Neoplasms (Cancer)
01/2019 - 01/2017
2Infections
01/2018 - 03/2017
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2017 - 01/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2008 - 07/2002
1Necrosis
03/2024
1Essential Hypertension
02/2024

Drug/Important Bio-Agent (IBA)

18CytokinesIBA
07/2023 - 01/2007
16Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2015
14Interleukin-6 (Interleukin 6)IBA
07/2021 - 01/2014
8Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2024 - 07/2002
7Ion Channels (Ion Channel)IBA
06/2023 - 01/2015
7AdipokinesIBA
11/2022 - 08/2014
6LipidsIBA
12/2023 - 12/2016
6AnkyrinsIBA
07/2023 - 01/2015
6Dinoprostone (PGE2)FDA Link
01/2020 - 05/2006
6CarrageenanIBA
01/2018 - 08/2013
5Interleukin-8 (Interleukin 8)IBA
10/2022 - 01/2019
5ResistinIBA
12/2021 - 01/2017
5AdiponectinIBA
12/2021 - 08/2014
5Matrix Metalloproteinases (MMPs)IBA
04/2020 - 01/2014
5Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2017 - 07/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 01/2019
4InterleukinsIBA
03/2024 - 01/2018
4Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 01/2017
4GlucocorticoidsIBA
03/2024 - 05/2013
4CollagenIBA
02/2023 - 01/2017
4Glucose (Dextrose)FDA LinkGeneric
09/2022 - 08/2014
4Clozapine (Clozaril)FDA LinkGeneric
12/2021 - 08/2014
4pinosylvinIBA
05/2021 - 03/2016
4Prostaglandin-E SynthasesIBA
12/2017 - 09/2011
3Bevacizumab (Avastin)FDA Link
03/2024 - 01/2019
3Mitogen-Activated Protein KinasesIBA
03/2024 - 03/2022
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2024 - 09/2011
3CationsIBA
07/2023 - 11/2016
3Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2019
3LeptinIBA
12/2021 - 02/2017
3Interleukin-4 (Interleukin 4)IBA
08/2021 - 12/2018
3C-Reactive ProteinIBA
12/2019 - 08/2014
3Glycoproteins (Glycoprotein)IBA
01/2019 - 01/2017
3EnzymesIBA
12/2017 - 09/2011
2taxaneIBA
03/2024 - 07/2019
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2024 - 05/2013
2OvalbuminIBA
03/2024 - 01/2019
2CreatinineIBA
12/2023 - 01/2018
2Interleukin-13IBA
07/2023 - 12/2018
2Bleomycin (Blenoxane)FDA LinkGeneric
02/2023 - 12/2018
2indium-bleomycinIBA
01/2023 - 12/2018
2Complement Factor D (Factor D)IBA
01/2023 - 02/2017
2PowdersIBA
09/2022 - 09/2022
2Fatty Acids (Saturated Fatty Acids)IBA
09/2022 - 05/2006
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2022 - 08/2014
2Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 07/2021
2Atrial Natriuretic Factor (ANF)IBA
01/2022 - 01/2019
2Urokinase Plasminogen Activator ReceptorsIBA
01/2022 - 01/2017
2E-SelectinIBA
01/2022 - 01/2019
2Antipsychotic Agents (Antipsychotics)IBA
12/2021 - 08/2014
2RNA (Ribonucleic Acid)IBA
01/2021 - 11/2020
2Interleukin-1 (Interleukin 1)IBA
01/2020 - 01/2003
2ProstaglandinsIBA
01/2020 - 12/2017
2ChitinasesIBA
01/2019 - 01/2017
2StilbenesIBA
12/2018 - 01/2018
2nortrachelogeninIBA
12/2018 - 04/2017
2Phosphodiesterase 4 InhibitorsIBA
12/2017 - 08/2013
2HDL CholesterolIBA
12/2016 - 08/2014
1Neuropilin-1IBA
03/2024
1ChemokinesIBA
03/2024
1Therapeutic UsesIBA
03/2024
1Thymic Stromal LymphopoietinIBA
03/2024
1Antihypertensive Agents (Antihypertensives)IBA
02/2024

Therapy/Procedure

5Drug Therapy (Chemotherapy)
03/2024 - 10/2018
3Adjuvant Radiotherapy
02/2020 - 10/2018
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2022 - 12/2012
2Therapeutics
02/2020 - 01/2017
2Heart Transplantation (Grafting, Heart)
10/2015 - 01/2014